Skip to main content
. Author manuscript; available in PMC: 2016 May 6.
Published in final edited form as: Entropy (Basel). 2015 Jul 27;17(8):5288–5303. doi: 10.3390/e17085288

Figure 3.

Figure 3

Median of the number of patients per trial for EWOC, EWOC-PO and AT (starting dose, accelerated phase increase rate, MF-UD increase rate) under nine scenarios. Each symbol represents 1000 simulated trials. The number of patients per EWOC and EWOC-PO trial is set to 30. The maximum number of patients per AT trial is 62 patients.